Rankings
▼
Calendar
IRWD Q3 2022 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$629M
Q3 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$109M
+4.7% YoY
Gross Profit
$108M
99.7% margin
Operating Income
$68M
63.0% margin
Net Income
$50M
46.3% margin
EPS (Diluted)
$0.27
QoQ Revenue Growth
+11.7%
Cash Flow
Operating Cash Flow
$69M
Free Cash Flow
$69M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$1.0B
Total Liabilities
$449M
Stockholders' Equity
$591M
Cash & Equivalents
$575M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$109M
$104M
+4.7%
Gross Profit
$108M
$93M
+16.6%
Operating Income
$68M
$65M
+5.1%
Net Income
$50M
$56M
-9.9%
Revenue Segments
Collaborative arrangements revenue
$109M
99%
Collaborative arrangement, co-promotion agreements
$814,000
1%
Collaborative arrangement, other agreements
$365,000
0%
Collaborative arrangement, collaboration and license agreements
$144,000
0%
Geographic Segments
Canada and Mexico
$900,000
51%
North America
$861,000
49%
← FY 2022
All Quarters
Q4 2022 →